<DOC>
	<DOCNO>NCT01146535</DOCNO>
	<brief_summary>This study aim evaluate safety effect interferon-alpha lozenge use combination oseltamivir ( Tamiflu ) treat influenza .</brief_summary>
	<brief_title>Interferon Alpha Lozenges Plus Oseltamivir Influenza Treatment</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Virus Diseases</mesh_term>
	<mesh_term>Interferons</mesh_term>
	<mesh_term>Oseltamivir</mesh_term>
	<mesh_term>Interferon-alpha</mesh_term>
	<criteria>fever &gt; =38C one respiratory symptom ( e.g . cough , rhinorrhea sore throat ) plus one constitutional symptom ( e.g . chill , headache , malaise myalgia ) &lt; 48 hour ' duration body weight &gt; 40 kg positive influenza A ( nasal swab rapid test ) pregnancy/lactation history depression psychiatric disorder history condition could complicate flu infection , chronic pulmonary , cardiac , renal , metabolic disorder use immunosuppressive therapy HIV infection</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2013</verification_date>
	<keyword>interferon-alpha</keyword>
	<keyword>oseltamivir</keyword>
	<keyword>drug therapy , combination</keyword>
	<keyword>influenza</keyword>
	<keyword>therapy , investigational</keyword>
</DOC>